Emmanuel Profile picture
Oct 13, 2024 15 tweets 6 min read Read on X
IMMUNOGENICITY to SARS-COV-2 ?
(Mega-thread🧵 with 7 studies just published ! 💯)

We need to approach this topic, with a lot of humility, acknowledging that we are just starting to grasp the complexities of our immune system's response to SARS-CoV-2. Image
2) "Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a two-year follow-up of the prospective clinical trial COVAXID"

Immunocompromised patients often don't respond well to COVID-19 vaccines ... thelancet.com/journals/ebiom…Image
3)..leading to the need for extra booster shots. In a 2-year study of 364 patients from a trial, blood samples showed that more vaccine doses and past infections improved immune responses, despite some treatments weakening them. Continuous boosters are crucial for these patients. Image
4) "Broad immunogenicity to prior SARS-CoV-2 strains and JN.1 variant elicited by XBB.1.5 vaccination in nursing home residents"

The XBB.1.5 COVID-19 vaccine enhances immunity among nursing home residents (NHRs) and healthcare workers (HCWs)
... link.springer.com/article/10.100…Image
5) ...particularly against new variants. A study showed that NHRs who had prior COVID-19 infections produced higher antibody levels after vaccination. This suggests the XBB.1.5 vaccine is effective in boosting protection for vulnerable populations.
6) "Functional Activity and Binding Specificity of small Ankyron Repeat Proteins against SARS-CoV-2 variants"

To manage COVID-19 effectively, we need both vaccines and treatments. Researchers have created special proteins called Ankyrons ... biorxiv.org/content/10.110…Image
7)...that can attach to the virus. These proteins can be made in the lab and bind tightly to the SARS-CoV-2 virus. Tests showed that some Ankyrons work against different virus variants. They also can neutralize the virus in lab tests and could help develop new treatments quickly
8) "Structural insights into the RNA binding inhibitors of the C-terminal domain of the SARS-CoV-2 nucleocapsid"

The SARS-CoV-2 nucleocapsid (N) protein helps protect and package the virus's genetic material. A study tested 3 antibiotics, ceftriaxone ... biorxiv.org/content/10.110…Image
9)..cefuroxime, and ampicillin to see if they could disrupt this packaging. Results showed that these drugs can inhibit RNA binding to the N protein. Structural analysis revealed new interaction sites, suggesting that targeting the N protein could lead to new antiviral treatments Image
10) "A Modular Bacteriophage T4 Nanoparticle Platform Enables Rapid Design of Completely Protective Multivalent Mucosal Dual Vaccine Against COVID-19 and Flu"

The COVID-19 pandemic and flu outbreaks highlight the need for better vaccines. biorxiv.org/content/10.110…Image
11) Current vaccines have issues like weak protection and less effectiveness against new variants. A new vaccine design uses bacteriophage T4 nanoparticles to target both COVID-19 and flu. It delivers vaccines through the nose for better immunity and includes various antigens... Image
12)..for wider protection. Tests in mice show strong immune responses, including antibodies and T cells, offering complete protection. This T4 platform can quickly create vaccines and is easy to produce, making it suitable for global use, especially in areas with fewer resources. Image
13) One of my favourite 🤗
"Distinct proteomic signatures in Ethiopians predict acute and long-term sequelae of COVID-19"

This study focuses on COVID-19 in African patients, who may react differently compared to other populations. medrxiv.org/content/10.110…Image
14) Researchers looked at proteins in patients' blood to find markers that could predict severe illness and the risk of Long COVID. They found specific proteins linked to severe cases and identified some that could indicate a higher or lower chance of developing Long COVID. Image
15) And to conclude a study posted yesterday.
Thanks for reading 🙏

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Emmanuel

Emmanuel Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @ejustin46

Apr 29
Why is Identifying "Non-Trivial SARS-CoV-2 Population Structure within Hosts" Important for Understanding SARS-COV-2 Evolution and the Emergence of New Variants?

journals.plos.org/plospathogens/…Image
2) The "non-trivial population structure" refers to the viral population within a host consisting of two or more distinct, independently evolving subpopulations, rather than a single, homogeneous population. Image
3) The key points about non-trivial population structure are:
▶️ It was relatively common, found in 5 out of the 9 chronic SARS-CoV-2 infection cases examined.
▶️ It was more prevalent in severely immunocompromised individuals compared to those not significantly immunocompromised Image
Read 7 tweets
Apr 26
No, Omicron is not the "humanized" SARS-COV-2 !

(Explanation in simple terms)
biorxiv.org/content/10.110…Image
2) Viruses are not living things. They are tiny particles that can only make copies of themselves inside the cells of living things, like humans. When a virus makes copies of itself, it doesn't always make perfect copies.
3) Sometimes, little mistakes happen, and the new virus has a small change, or mutation, in its genes.

Most of the time, these mutations don't do anything useful for the virus. But every now and then, a mutation might happen that makes the virus better at infecting people. Image
Read 7 tweets
Apr 26
"What if humans had sent SARS-COV-2 into space, or even brought COVID-19 along for astronauts?"

biorxiv.org/content/10.110…Image
2) This study looks at the risks of COVID-19 for people traveling to space.

Space travel is becoming more common, with over 600 people having gone to space. But COVID-19 could be a big problem for astronauts in the unique environment of space. Image
3) The study aims to understand how COVID-19 might behave differently in space compared to on Earth.

The researchers reviewed studies on other airborne diseases in space. They found that some diseases, like Epstein-Barr virus and Serratia bacteria ... Image
Read 6 tweets
Apr 24
From Lung Damage to Gut Dysbiosis:
The Lasting Implications of SARS-CoV-2 Variant-Specific Microbiome Changes (From Wuhan strain to Omicron)
labanimres.biomedcentral.com/articles/10.11…Image
2) The Wuhan strain of SARS-CoV-2 caused serious damage to the lungs of infected mice. The mice had a very high chance of dying from this strain. The researchers also looked at the bacteria in the lungs and guts of the infected mice. Image
3) The Wuhan strain increased harmful bacteria like E. coli in the lungs. This can make the lungs more prone to other infections.

The Omicron variant caused different changes in the gut bacteria of the mice. It increased certain bacteria linked to inflammation in the gut. Image
Read 5 tweets
Apr 23
What are GAMMA CORONAVIRUSES ?
And why did we decide to talk about it? Image
Image
2) A brief reminder :

▶️ SARS-CoV-2 belongs to the family Coronaviridae, is classified as a coronavirus and is responsible for COVID-19
▶️ Bird Flu refers to various strains of the influenza virus, particularly those in the Orthomyxoviridae family including H5N1 and H7N9. Image
3) ▶️ Gammacoronavirus belongs to the family Coronaviridae like SARS-COV-2.

Some notable gammacoronaviruses include:
- Infectious Bronchitis Virus (IBV): A major pathogen in poultry responsible for respiratory disease and reduced egg production. Image
Read 10 tweets
Apr 21
A TREATMENT that Could Finally END Long COVID Suffering ?

This isn't the first time a treatment has been announced, and as millions continue to struggle with long Covid, we need to remain both cautious and hopeful 🤗 Image
2) Researchers at WEHI announced that they discovered a new drug that can stop long COVID symptoms in mice. This drug is more effective than the current top treatment, Paxlovid, for both long COVID and acute COVID cases. Image
3) They focused on a specific protein called PLpro that other treatments haven't targeted well. This breakthrough could lead to new medicines for long COVID, a condition where people continue to feel sick long after their COVID-19 infection. Image
Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(